Literature DB >> 407965

Antibodies against BCG antigen 60 in mycobacterial infection.

M Harboe, O Closs, B Bjorvatn, G Bjune.   

Abstract

A sensitive specific radioimmunoassay was developed to measure antibodies against BCG antigen 60, a prominent antigenic component of BCG bacilli which cross-reacts with similar components in many mycobacterial species including Mycobacterium leprae and M tuberculosis. A lepromatous serum pool had anti-BCG-60 activity with a titre of 10(5) and the tuberculoid pool a titre of 10(4). Testing of individual sera showed striking variations within groups of patients with lepromatous and tuberculoid leprosy. In five of the 20 tuberculoid leprosy sera the anti-BCG-60 activity was above the median for the lepromatous group. The current view that antibody formation against mycobacterial antigens is very low in tuberculoid leprosy thus no longer appears to be tenable. Sera from eight patients with active pulmonary tuberculosis also showed a striking variation in anti-BCG-60 content, and the median value of this group was even higher than in those with lepromatous leprosy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407965      PMCID: PMC1631241          DOI: 10.1136/bmj.2.6084.430

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.

Authors:  M Harboe; O Closs; K Svindahl; J Deverill
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

2.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

3.  The use of protein A-containing Staphylococcus aureus as a solid phase anti-IgG reagent in radioimmunoassays as exemplified in the quantitation of alpha-fetoprotein in normal human adult serum.

Authors:  S Jonsson; G Kronvall
Journal:  Eur J Immunol       Date:  1974-01       Impact factor: 5.532

4.  Experimental Arthus reactions using the same antigen in soluble and corpuscular form.

Authors:  A Sudarsanam; J Grabosz; B Myklestad; B Myrvang; M Harboe
Journal:  Afr J Med Sci       Date:  1971-10

5.  Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.

Authors:  S N Wemambu; J L Turk; M F Waters; R J Rees
Journal:  Lancet       Date:  1969-11-01       Impact factor: 79.321

6.  Significance of variations within the lepromatous group.

Authors:  D S Ridley; M F Waters
Journal:  Lepr Rev       Date:  1969-07       Impact factor: 0.537

7.  Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG).

Authors:  M Harboe; O Closs; J Deverill
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

8.  Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci.

Authors:  M Harboe; I Fölling
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

Review 9.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

10.  BCG antibody profiles in tuberculoid and lepromatous leprosy.

Authors:  N H Axelsen; M Harboe; O Closs; T Godal
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more
  12 in total

1.  Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

Authors:  R D Hubbard; C M Flory; F M Collins; C Cocito
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy.

Authors:  U Barros; V P Shetty; N H Antia
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Subcellular localisation and sedimentation behaviour of antigen 60 from Mycobacterium bovis BCG.

Authors:  C Cocito; F Vanlinden
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

4.  Research in leprosy. A report of a committee set up by the medical research council to study future prospects.

Authors: 
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

5.  Delayed hypersensitivity reactions by the mycobacterial antigen A60 and cutaneous testing in tuberculosis.

Authors:  C Benoit; A Beschin; M Desmecht; P Dekeyser; C Cocito
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

6.  Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.

Authors:  R Melsom; M Harboe; B Myrvang; T Godal; A Belehu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

7.  Preparation and properties of antigen 60 from Mycobacterium bovis BCG.

Authors:  C Cocito; F Vanlinden
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

8.  Serological response of tuberculosis patients to antigen 60 of BCG.

Authors:  M J Gevaudan; C Bollet; D Charpin; M N Mallet; P De Micco
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

9.  Metabolism of the TMA group of antigens during the growth cycle of mycobacteria.

Authors:  C Cocito; F Vanlinden
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

10.  Comparative cutaneous testing with purified protein derivative and the antigen complex A60 in vaccinated subjects and tuberculosis patients.

Authors:  Y L Zou; J D Zhang; M H Chen; G Q Shi; C Cocito
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.